Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). (Q43158828)
Jump to navigation
Jump to search
scientific article published on 15 February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). |
scientific article published on 15 February 2010 |
Statements
1 reference
Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: a phase 2 study (SOGUG-02-06). (English)
1 reference
1 reference
1 reference
Joaquim Bellmunt
1 reference
José Manuel Trigo
1 reference
Emiliano Calvo
1 reference
Jordi Rubió
1 reference
Juan Antonio Virizuela
1 reference
Rafael López
1 reference
Martín Lázaro
1 reference
Joan Albanell
1 reference
15 February 2010
1 reference
1 reference
11
1 reference
4
1 reference
350-357
1 reference
Identifiers
1 reference
1 reference